A benchmarking study on multiple GNNs on a Protein-Protein Interaction (PPI) network for Kidney Renal Clear Cell Carcinoma and Breast cancer subtype prediction, performing an in-depth investigation of architectures, incorporating skip connections and various data modalities.
Abstract
Motivation Graph Neural Networks (GNNs) have gained increasing interest in the biomedical domain, as the integration of prior knowledge and deep neural networks has the potential to enhance insights into molecular processes and disease mechanisms. However, a comprehensive and systematic assessment of model architectures, data modalities, graph structures, and their performance for graph signal classification in the biomedical domain is yet to be performed. In order to close this gap, we conducted a benchmarking study on multiple GNNs on a Protein-Protein Interaction (PPI) network for Kidney Renal Clear Cell Carcinoma and Breast cancer subtype prediction, performing an in-depth investigation of architectures, incorporating skip connections and various data modalities. Results While none of the GNNs outperforms the structure-agnostic Multi-Layer Perceptron baseline, all of them can handle bimodal data (gene methylation and expression) and offer the ability to gain explainability based on PPIs. We offer practical guidelines for applying GNNs to graph signal processing tasks specifically for cancer classification. Depending on the underlying dataset and PPI structure employed, models on different data modalities outperform others. Overall, we suggest using ChebNet, which tends to outperform the Graph Convolutional Network and the Graph Attention Network in cancer subtype prediction. We recommend using GNN architectures that employ a simple flattening readout layer, as they provide better classification performance and faster training time than those with global average pooling. Additionally, we tested residual connections, but they had only an insignificant impact on classification performance. Availability and implementation Code and data available at https://github.com/HauschildLab/GNN4PPI. Contact julia.schirmacher@med.uni-goettingen.de, anne-christin.hauschild@uni-gießen.de Supplementary information Supplementary data attached.
This chapter provides a comprehensive technical protocol for predicting CDGs using a Graph Convolutional Network (GCN) and guides the reader through hyperparameter optimization, model training, and performance evaluation, while discussing practical considerations related to generalization, computational cost, and inter...
Renan Soares de Andrades, M. Recamonde-Mendoza· Methods in molecular biology· 0 citations
The proposed engGNN is highlighted as a robust, flexible, and interpretable framework for disease classification and biomarker discovery in high-dimensional omics contexts and provides interpretable feature importance scores that facilitate biologically meaningful discoveries, such as pathway enrichment analysis.
Tian-Tian Yang, Yuxuan Wang, Zhen-Wei Zhou et al.· Briefings in Bioinformatics· 0 citations
Paired Wilcoxon tests in 39 AURORA-US patients with matched primary and metastatic samples confirm that 4 of the 10 IG-identified TFs are significantly altered during metastatic progression after Bonferroni correction.
C. Fernandez-Lozano, David Ferreiro, Patricia V.-del-Río· bioRxiv· 0 citations
A new multi-omics integration framework that combines a Sparse Autoencoder that compresses the high-dimensional genome data and a Protein-Protein Interaction focused Graph Attention Network that forms a structure of interrelated biological activities that are incorporated within the proteomic communication framework.
S. K., A. G, Mustafa Basthikodi· International journal of com...· 0 citations
The results illustrate that a late-fusion RGCN ensemble effectively captures complex gene interactions, overcoming limitations of existing models and providing a framework for future biomarker discovery.
Samarth Khandelwal, J. Zhan, Nicholas Jarvis· bioRxiv· 0 citations
Findings show that patient-graph construction is a key design choice in pan-cancer multi-omics learning and that leakage-controlled evaluation is essential for reliable and biologically informative benchmarking in computational oncology.